The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bms france; MSD Oncology; Novartis; Sun pharma
Consulting or Advisory Role - BMS GmbH & Co. KG; Novartis; Sun Pharma
Research Funding - MSD Oncology (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Roche/Genentech; Roche/Genentech
Avelumab as second-line or later (2L+) treatment in patients (pts) with metastatic Merkel cell carcinoma (mMCC): Analysis of real-world outcomes in France using the CARADERM registry and the French national healthcare database.
 
Astrid Blom Fily
Consulting or Advisory Role - Merck KGaA
Travel, Accommodations, Expenses - Merck KGaA
 
Laurent Mortier
No Relationships to Disclose
 
Isabelle Kachaner
Employment - Pfizer
 
Nicolas Meyer
Consulting or Advisory Role - Bristol-Myers Squibb; Merckle GmbH; MSD Oncology; Novartis; Pierre Fabre; Sun Pharma
Research Funding - Bristol-Myers Squibb (Inst); MSD Oncology (Inst)
 
Mahtab Samimi
Honoraria - Amgen; Novartis
Consulting or Advisory Role - Merck KGaA; Pfizer
Travel, Accommodations, Expenses - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Galderma; Janssen-Cilag; Lilly; Merck; Pierre Fabre; Sanofi
 
Laura Luciani
Employment - Merck KGaA
 
Capucine Cahuzac
Employment - Merck KGaA
 
Caroline Robert
Stock and Other Ownership Interests - Ribonexus
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck; Novartis; Pierre Fabre; Roche; Sanofi; Sun Pharma
 
Gaëlle Quéreux
No Relationships to Disclose
 
Eve Maubec
Consulting or Advisory Role - Novartis; Pierre Fabre; Sanofi
Research Funding - MSD (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Novartis; Pierre Fabre
 
Cathy Maillard
No Relationships to Disclose
 
Hakima Miotti
No Relationships to Disclose
 
François Aubin
Consulting or Advisory Role - Abbvie; Amgen; BMS; Celgene; Janssen-Cilag; LEO Pharma; MSD Oncology; Novartis; Sanofi
 
Cédric Lenormand
No Relationships to Disclose
 
Marie-Noelle Solbes
Employment - Merck KGaA
 
Pascal Joly
Consulting or Advisory Role - Argenx; AstraZeneca; Lilly O.; Novartis; Principa Biopharma; Roche; Sanofi
 
Benoît van Hille
Employment - Merck KGaA
 
Celeste Lebbe
Honoraria - Amgen; Bristol-Myers Squibb; Incyte; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Sanofi
Other Relationship - Avantis Medical Systems; BMS; InflaRx; Jazz Pharmaceuticals; MSD; Novartis; Pierre Fabre; Sanofi
 
Caroline Dutriaux
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Philippe Saiag
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche/Genentech; Sanofi
Research Funding - Pierre Fabre
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; pierre fabre; Roche